Pharmaceutical products in Ethiopia are regulated by the Ethiopian Food and Drug Authority (EFDA) under the Food and Medicine Administration Proclamation No. 1112/2019. Ethiopia has introduced regulatory requirements to improve medicine traceability and combat counterfeit pharmaceutical products.
The EFDA requires pharmaceutical manufacturers and importers to implement serialization using GS1 compliant DataMatrix barcodes on medicine packaging. The system enables verification of medicines and supports supply chain monitoring from manufacturers and importers through distribution.
The Ethiopian traceability framework is designed to align with global GS1 identification standards and supports electronic verification of medicines throughout the supply chain. Serialization requirements apply primarily to human prescription medicines and selected priority pharmaceutical products.